Oxford Textbook of Psoriatic Arthritis

Professor Oliver FitzGerald is a consultant rheumatologist at St Vincent's University Hospital, and the Newman Clinical Research Professor at the Conway Institute of Biomolecular and Biomedical Research at University College Dublin. He has published over 280 peer-reviewed papers, and his main research interests include the clinical and therapeutic studies of psoriatic arthritis, the development of novel imaging techniques for measuring synovial or entheseal inflammation, and studies of gene and protein expression in diseased tissue. He also serves as a council member for the Group for Research and Assessment is Psoriasis and Psoriatic Arthritis (GRAPPA), and is developing a longitudinal study of soluble biomarkers with the OMERACT group. Dr Dafna Gladman is a senior scientist at the Toronto Western Research Institute, University Health Network and Professor of Medicine at the University of Toronto. She heads the Centre for Prognosis in Rheumatic Diseases, which currently studies areas including Systemic Lupus Erythematosus and Psoriatic Arthritis, and is co-director of the Psoriatic Arthritis at the UHN Arthritis Program. She has over 520 peer-reviewed publications, including important contributions to the field such as identifying predictors for disease progression and mortality. She received the Verna Wright Prize for outstanding contributions to the field of Psoriatic Arthritis by the International psoriatic Arthritis Group.

Introduction
1: Dafna Gladman and Oliver FitzGerald: Introduction to Psoriatic Arthritis
Epidemiology
2: Joel Gelfand and Junko Takeshita: Epidemiology of Psoriasis
3: Elaine Husni and Madonna Michael: Epidemiology of Psoriatic Arthritis
Pathogenesis
4: Kurt De Vlam: Overview of Psoriatic Arthritis Pathogenesis
5: Philip E. Stuart, Lam C. Tsoi, Caely A. Hambro, and James T. Elder: Genetics of Psoriasis
6: Robert Winchester and Proton Rahman: Genetics of Psoriatic Arthritis
7: Bruce Kirkham: Immunology and Cytokine Pathways
8: Rik Lories: Mechanisms of bone destruction and proliferation
Clinical features
9: Cheryl F. Rosen and Brian Kirby: Psoriasis and Nail
10: Raffaele Scarpa, Francesco Caso, Luisa Costa, Rosario Peluso, Nicola Matteo Dario Di Minno, and Antonio Del Puente: Peripheral arthritis
11: Juan D. Cañete and Julio Ramírez: Enthesitis
12: Ignazio Olivieri, Enrico Scarano, Salvatore D'Angelo, Carlo Palazzi, and Angela Padula: Dactylitis
13: Ennio Lubrano: Axial disease
14: Filip Van den Bosch: Extra-articular, extra-skin disease
15: Muhammad Haroon: Co-morbidities
Imaging
16: Neil McHugh and William Tillett: Plain radiography
17: Gurjit Kaeley: Ultrasound
18: Dennis McGonagle and Iris Eshed: MRI
19: Georg Schett and Camille Figueiredo: MicroCT
Diagnosis and classification
20: Laura Coates and William Taylor: Diagnosis and classification criteria
Outcome and biomarkers
21: Lihi Eder: Clinical course and outcome
22: Vinod Chandran and Katerina Oikonomopoulou: Biomarkers of psoriatic arthritis outcome
Domains, instruments, and composite scores
23: Alberto Cauli: Domains and instruments
24: Laure Gossec, Maarten de Wit, and Tania Gudu: Patient-related outcome measures
25: Philip Helliwell: Composite scores
Treatment
26: Alice Gottlieb, Ami Saraiya, and Deep Joshipura: Psoriasis treatment
27: Enrique Soriano and Laura Acosta Felquer: Approach to management and symptomatic (including non-pharmacologic) management of PsA
28: Frank Behrens, Michaela Koehm, and Michael J. Pamham: Synthetic DMARDS
29: Arthur Kavanaugh and Tristan Boyd: Biologic DMARDS (TNFi)
30: Philip Mease: Non-TNF Biologic DMARDS
31: Laura Coates, Arthur Kavanaugh, and Christopher Ritchlin: Treatment algorithm and treat to target
Future directions
32: Dafna Gladman and Oliver FitzGerald: Future directions